Background/Aims: The status of interferon (IFN) signaling pathway has been shown to be closely associated with the response of immune checkpoint blockade therapy against advanced human cancers. IFN-induced protein with tetratricopeptide repeats 2 (IFIT2), also known as IFN-stimulated gene 54 (ISG54), is one of the most highly responsive ISGs, which can inhibit the proliferation and migration of cancer cells, and regulate viral replication, resulting in anti-cancer and anti-viral effects. In the present study, we aimed to investigate the role of IFIT2 in human gastric cancer. Methods: Immunohistochemistry assay was used to investigate the correlation between the IFIT2 expression in cancer tissues and clinical parameters of gastric cancer patients. Knockdown of IFIT2 was performed using RNAi to assess the role of IFIT2 in the regulation of biological behaviors in human gastric cancer cell lines. Results: IFIT2 expression in gastric cancer tissues was significantly associated with tumor stage and postoperative prognoses of the patients. Moreover, decreased IFIT2 expression in human gastric cancer cell lines SGC-7901 and AGS significantly increased the cell viability, cell migration and the ratios of cells in S phase. Conclusion: Our present study demonstrated that the decreased IFIT2 expression could promote the gastric cancer progression and predict poor therapeutic outcomes of the patients.
Introduction
Numerous clinical trials have shown that the immune checkpoint blockade is the most promising approach to activate the effective anti-tumor immunity [1] . For example, antibodies against the cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death protein-1 (PD-1) have been widely used in the therapeutic strategies of advanced cancers [2] . However, although the immune checkpoint blockade significantly contributes to responses against cancers, there still remains immune resistance due to individual differences, resulting in treatment failure and cancer progression [3] . Recently, several reports have demonstrated that the loss of interferon (IFN) pathway genes in tumor cells poses a great obstacle to immune checkpoint blockade therapy, leading to immune resistance and treatment failure [4] . As shown in this report, the authors pinpointed that the expression pattern of IFN pathway genes was significantly different between the responders and non-responders in anti-CTLA-4 treatment, including the IFN-stimulated gene (ISG) family protein, IFN-induced protein with tetratricopeptide repeats 2 (IFIT2) [4] .
IFIT2, also known as ISG54, is one of the most highly responsive ISGs. It can inhibit the proliferation and migration of cancer cells and regulate viral replication, exerting an anticancer as well as anti-viral effect mediated by IFN [5] [6] [7] [8] . The expression of IFIT2 can also promote cell death via apoptosis through a mitochondrial pathway dependent on Bcl2 [9] . Previous studies have suggested that the expression level of IFIT2 in human cancer tissues is highly correlated with clinical parameters and therapeutic outcomes of patients. Lai et al. have demonstrated that decreased IFIT2 expression in human oral squamous cell carcinoma is significantly associated with poorer survival of patients [6] . However, the exact role of IFIT2 expression in human cancer progression and its relationship to therapeutic outcomes of patients remain largely unexplored.
In our present study, we aimed to establish the correlation between the IFIT2 expression in human gastric cancer tissues and therapeutic outcomes of patients. Furthermore, we also attempted to investigate the regulatory role of IFIT2 in cellular functions of human gastric cancer cell lines, SGC7901 and AGS. Our immunohistochemistry results indicated that higher IFIT2 expression was correlated with better survival of gastric cancer patients. Moreover, knock-down of IFIT2 significantly increased the proliferation, migration and invasion abilities of human gastric cancer cell lines. Therefore, our findings highlighted that the decreased IFIT2 expression could promote the gastric cancer progression and predict poor prognoses of the cancer patients.
Materials and Methods

Patients and sample collection
The gastric cancer tissue array (Catalog number: HStm-Ade180Sur-05) was purchased from Shanghai Outdo Biotech Co., Ltd. (Shanghai, P. R. China). A total of gastric cancer 90 patients (aged from 32 to 84 years old, with a median age of 63) who underwent surgery from July 2006 to April 2007 were included in the present study. No patient received pre-operative chemotherapy or radiotherapy, and all tumor tissues were confirmed as gastric cancer using hematoxylin and eosin (H&E) staining after surgical resection. Formalinfixed, paraffin-embedded tissue blocks from the gastric cancer tissues as well as the corresponding adjacent normal tissues from 90 cases of gastric cancer patients were included in the tissue-array. The tumor-nodemetastasis (TNM) stages were assigned according to the American Joint Committee on cancer criteria. All available survival data of the 90 cases were used in the survival analysis. After excluding the incomplete tissue points and several missing tissue points when performing the heated antigen retrieval, finally there were 84 cases involved in the statistical analysis. The detailed clinical parameters of the patients are shown in Table 1 .
Antibodies and other reagents
The rabbit anti-human IFIT2 polyclonal antibody (ab113112, diluted in 1:80) was purchased from Abcam (Cambridge, MA, USA). The HRP-labeled goat anti mouse/rabbit secondary antibodies (K500711) were obtained from Dako (Glostrup, Denmark). In addition, rabbit anti-human GAPDH (Sigma, St. Louis, MO, USA) was used for Western blotting analysis. The RNeasy Mini Kit was supplied from Qiagen (Valencia, CA, USA), and SYBR Green Master Mix kits were provided by TaKaRa (Dalian, China). RPMI-1640 medium and fetal bovine serum (FBS) were purchased from Gibco (Cambrex, MD, USA). 
Immunohistochemical staining
The expression of IFIT2 at the protein level in human gastric cancer tissues as well as adjacent normal tissues was detected using immunohistochemistry assay. Briefly, the paraffin-embedded tumor tissue array block was sectioned into 3-mm sections, dewaxed using xylene and rehydrated in a graded series of alcohols. Subsequently, antigen retrieval was performed by heating the tissue section at 100°C for 30 min in a citrate solution (10 mM, pH 6.0). After cooling of the section, tissue sections were immersed in 0.3% hydrogen peroxide solution for 15 min to block endogenous peroxidase activity, and then the sections were rinsed in PBS for 5 min and blocked with 3% BSA solution at room temperature for 20 min. Next, the sections were incubated with rabbit anti-human IFIT2 polyclonal antibody at 4°C overnight and then incubated with HRP-labeled goat anti mouse/rabbit secondary antibody. Diaminobenzene was used as the chromogen, and hematoxylin was used as the nuclear counterstain. Finally, the sections were dehydrated, cleared and mounted.
All slides were blindly examined by two independent senior pathologists. The immunostaining intensity of IFIT2 was assessed according to the H-score method as previously described [10, 11] : H-score = (% unstained tumor cells x0) + (% weakly stained tumor cells x1) + (% moderately stained tumor cells x2) + (% strongly stained tumor cells x3). The H-scores ranged from 0 (100% negative tumor cells) to 300 (100% strongly stained tumor cells). The scoring results from the two pathologists for each protein were averaged and used for statistical analysis.
Cell lines and cell culture
Human gastric cancer cell lines, SGC-7901 and AGS, were obtained from Chinese Academy of Sciences, Shanghai Institutes for Biological Sciences (Shanghai, China). The cell lines were cultured in RPMI-1640 medium supplemented with 10% FBS in the presence of benzylpenicillin (100 U/mL), streptomycin (100 μg/mL) and 2 mM L-glutamine. The cells were incubated at 37°C in an environment of 5% CO 2 .
RNAi lentivirus generation, infection and cell sorting
SGC-7901 and AGS cells were used for the knockdown of IFIT2 small hairpin RNA (shRNA) against the human IFIT2 gene (NM_001547.4; GenBank) was obtained from Shanghai Generay Biotech Co., Ltd.
(Shanghai, China) and cloned into a lentiviral gene transfer vector encoding green fluorescent protein 
Real-time polymerase chain reaction (RT-PCR)
The expression of IFIT2 at the mRNA level in different human gastric cancer cell lines was assessed by RT-PCR. Total RNA was extracted from various cell lines by TRIzol reagent (Invitrogen, USA), and PCR reactions were performed using the ABI 7600 system (Applied Biosystems, USA) according to the manufacturer's instructions. Human GAPDH was selected as a housekeeping gene to normalize the expression level of target gene. Primers were synthesized as follows: GAPDH forward primer: 5´-TGACTTCAACAGCGACACCCA-3´; GAPDH reverse primer: 5´-CACCCTGTTGCTGTAGCCAAA-3´; IFIT2 forward primer: 5´-GCGAAACAACTGCTCCATCT-3´; IFIT2 reverse primer: 5´-CCAAGACATGCAAAGCCTCA-3´. The relative expression of target gene was calculated with the 2 -ΔΔCT method.
Western blotting analysis
The expression of IFIT2 at the protein level in different cellular models was determined by western blotting analysis. Briefly, whole cell extracts were prepared from 1x10 6 cells using RIPA lysis buffer (50 mM Tris/HCl pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 0.25% Na-eoxycholate, 1 mM EDTA and protease inhibitor cocktail). Cells were lysed on ice for 30 min, and the cell lysates were collected in microtubes and centrifuged at 12, 000 rpm for 15 min at 4°C. After centrifugation, supernatants were collected, and the protein concentrations were determined using a BCA Protein Assay Kit (Beyotime, Jiangsu, China). Equal amounts of denatured proteins were separated by SDS-PAGE and transferred onto PVDF membranes (Millipore, USA). The membranes were then blocked with 5% non-fat dry milk in TBS-T (20 mM Tris, pH 7.4, 137 mM NaCl, 0.05% Tween-20) at room temperature for 3 h and then incubated with primary antibodies at 4°C overnight. Subsequently, blots were washed and incubated with secondary antibodies at room temperature for 1 h, followed by rinse with PBST for three times. Finally, immuno-reactive protein bands were detected using an Odyssey Scanning system (Li-Cor, Lincoln, NE, USA).
Cell viability assay
Cell viability was assessed by using Cell Counting Kit-8 (CCK-8, Beyotime, Shanghai, China) according to the manufacturer's instructions. Briefly, 5×10 3 SGC-7901 or AGS cells from LV-NC and LV-IFIT2-shRNA groups were seeded into 96-well plates and incubated for 24, 48 and 72 h. CCK-8 reagent was added to each well at 3 h before the endpoint of incubation, and absorbance of each well was determined at a wavelength of 450 nm by a microplate reader. An increase or decrease in the absorbance of experimental wells relative to the initial values indicates cell growth or death, respectively. Each experiment was repeated at least three times.
Wound healing assay
The effect of decreased IFIT2 expression on cell migration was examined by wound healing assay in both SGC-7901 and AGS cells. Briefly, SGC-7901 and AGS cells were cultured in 6-well plates. A small wound area was created using a 200-µL pipette tip when cells reached a 90% confluence. Cells were washed twice with PBS and then incubated in serum-free RPMI-1640 medium at 37°C for 48 h in a 5% CO 2 incubator. Photographs were taken at two different time points (0 and 24 h). Wound width was measured using a BX50 microscope (Olympus ® ) with a calibrated eyepiece grid. Data from three independent experiments were averaged and expressed as a percentage of the original width.
Transwell assay
The co-culture system was also used to evaluate the effect of decreased IFIT2 expression on the migration ability of human gastric cancer cells as previously described [12, 13] . The transwell assay was performed using Matrigel-coated invasion chambers (Corning, NY, USA). The cells (2x10 5 cells/well) from the different groups were serum-starved in the upper chamber for 24 h. Medium containing 10% FBS was placed in the lower chamber as a chemo-attractant. After 48 h of incubation, cells that migrated into the Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry lower chamber were collected and resuspended, and non-migrating cells were removed from the top of the Matrigel with a cotton-tipped swab. Migrated cells were fixed and stained with 0.1% crystal violet and later photographed under a microscope (Olympus, Tokyo, Japan). Finally, the migrated cells were counted from five randomly selected fields.
Cell cycle assay SGC-7901 or AGS cells from LV-IFIT2-shRNA and LV-NC groups were seeded in 6-well plates and cultured for 48 h. The cells were then washed with ice-cold PBS and fixed in a 70% (v/v) ice-cold ethanol solution at 4°C overnight. Subsequently, these cells were analyzed by flow cytometry according to the instructions of cell cycle analysis kit (Sigma, MO, USA). The cell cycle information was analyzed using ModFit LT 4.0 software.
Statistical analyses
Statistical analysis was conducted using the paired Student's t-test, the Wilcoxon signed-rank test, the Chi-square test or the Log-rank survival analysis where appropriate for final analysis of the data. The data were expressed as the mean and range or mean±SD of three independent experiments. All the statistical analyses were performed using the GraphPad Prism 5.0 software package (GraphPad Software, Inc., San Diego, USA). A p-value of <0.05 was considered as statistically significant.
Results
Expression of IFIT2 in human gastric cancer tissues and adjacent normal tissues
In order to assess the expression pattern of IFIT2 during the progression of human gastric cancer, we examined the IFIT2 expression in both human gastric cancer tissues and adjacent normal tissues using immunohistochemistry assay. Fig. 1A shows that the H-score of IFIT2 immunostaining in gastric cancer tissues was significantly lower than that of adjacent normal tissues (P<0.001). Fig. 2 reveals that the immunostaining of IFIT2 was predominantly localized in the cytoplasm of the gastric cancer cells and normal gastric mucosal epithelial cells. Table 1 displays that the IFIT2 expression in gastric cancer tissues was only correlated with the TNM stage of the patients (χ 2 =4.364, P=0.037), while it was not correlated with other clinical parameters, such as gender, age, tumor size, pathological stage, lymph node metastasis or distant metastasis. As shown in Fig. 1B and Table 2 , the decreased IFIT2 expression in gastric cancer tissues was also significantly associated with the poorer survival of the patients (HR=0.393, 95%CI: 0.124-0.571, P=0.001). The multivariate COX model analysis also showed that the IFIT2 expression and the distant metastasis could also be used as the independent prognostic predictors for gastric cancer patients (P=0.005 and P=0.021, respectively).
Knockdown of IFIT2 in human gastric cancer cell lines SGC-7901 and AGS
In order to further investigate the effect of IFIT2 on biological features of human gastric cancer Fig. 1 . IFIT2 expression in gastric cancer tissues and its prognostic value. A. The immunohistochemical staining of IFIT2 in both gastric cancer tissues and adjacent normal tissues was performed and analyzed, and the results showed that the IFIT2 expression in gastric cancer tissues was significantly decreased compared with adjacent normal tissues (P<0.001). B. The log-rank survival analysis also showed that the overall survival of the patients with higher IFIT2 expression was significantly better than those with lower IFIT2 expression (HR=0.393, 95%CI: 0.124-0.571, P=0.001). (Fig. 3A) . Fig. 3B and 3C show that after knockdown of IFIT2 in gastric cancer cell lines, its expression at the mRNA level in both SGC-7901 and AGS cells was significantly decreased (both P<0.005). Fig. 3D shows the western blotting results of the IFIT2 expression at the protein level in LV-NC and LV-IFIT2-shRNA groups, and the statistical analysis also indicated that the IFIT2 expression at the protein level of SGC-7901 and AGS cells in the LV-IFIT2-shRNA group was significantly decreased compared with the LV-NC group (Fig. 3E, P<0 .005 and P<0.0001, respectively). 
Knockdown of IFIT2 in human gastric cancer cells significantly affects the cell viability, migration and cell cycle
In order to further investigate the effect of knockdown of IFIT2 on the biological features of human gastric cancer cells, we performed CCK-8 assay, wound healing assay, transwell assay and cell cycle assay to examine the role of IFIT2 in cell viability, migration and cell cycle, respectively. Fig. 4A and 4B reveal that knockdown of IFIT2 in human gastric cancer cell lines SGC-7901 and AGS significantly increased the cell viabilities at 48 h and 72 h post-transfection (in SGC7901 cells, both P<0.05, in AGS cells, both P<0.005). Fig. 5A and 5B suggest that knockdown of IFIT2 significantly increased the cell migration ability in both SGC-7901 and AGS cells. At 24 h after cell scraping, the migrated distance in the LV-IFIT2-shRNA group was significantly increased compared with the LV-NC group in both SGC-7901 and AGS cells (both P<0.005). Furthermore, we also performed transwell invasion assay to confirm the cell migration abilities of SGC-7901 and AGS cells after knockdown of IFIT2, and the number of crystal violet-stained cells was significantly increased in the LV-IFIT2-shRNA group compared with the LV-NC group (both P<0.05 in SGC-7901 and AGS cells, Fig. 6 ). In Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
Discussion
It is well known that as a critical mediator of the innate as well as adaptive immune response, IFNs can inhibit viral replication and cellular proliferation and stimulate immune effector cells [14] . Therefore, IFNs exert important effects on tumor suppression by participating in immunosurveillance and immunoediting [15] . Different types of IFNs bind to distinct cell surface receptors, trigger the JAK/STAT signaling pathway and transcriptionally induce the expressions of ISGs [16, 17] . IFIT2, also known as ISG54, is one important member of ISGs, and numerous studies have shown that it plays an important role in anti-viral and anti-cancer effects [9] . More recent studies have indicated that the status of IFN pathway of the cancer cells may be decisive for the success of immune checkpoint immunotherapy [4, 18] . Among the molecules involving in the IFN pathway, IFIT2 has been also found to be significantly decreased in the cancer cells from patients who fail to respond to anti-CTLA-4 treatment [4] . Moreover, some studies have also shown that the decreased IFIT2 expression in cancer cells is significantly associated with poorer therapeutic outcomes of patients [6, 7] . Therefore, it is crucial to investigate the role of IFIT2 in cancer progression and cancer immunotherapy.
In our present study, we first reported that the decreased IFIT2 expression was found in gastric cancer tissues compared with adjacent normal tissues, and its expression was significantly associated with tumor stage and patients' postoperative prognoses. Lai et al. have reported that IFIT2 can inhibit the migration activity and increase the survival of patients with oral squamous cell carcinoma [6] . Therefore, we also performed cellular studies targeting IFIT2 in human gastric cell lines and further demonstrated that the decreased IFIT2 expression could significantly increase the cell viability and cell migration ability. Lai et al. have also reported that the decreased IFIT2 expression in human oral squamous cells can activate the PKC signaling pathway and promote the epithelial-mesenchymal transition (EMT) of the cancer cells [7] . Christian et al. have also shown that the down-regulation of IFIT2 can be regulated by the activated Ras/MEK signaling pathway [19] . Lai et al. have also found that the IFIT2 depletion can up-regulate the TNF-α secretion and further lead to angiogenesis and metastasis of OSCC cells [20] . Therefore, it is necessary to further investigate how the decreased IFIT2 expression in human gastric cancer cell lines regulates the cellular functions. Moreover, IFIT2 has been shown as an important role in promoting cell apoptosis. The expression of IFIT2 can also promote cell death via apoptosis through a mitochondrial pathway dependent on Bcl2 [9] . Feng et al. have reported that the expression of microRNA-645 can be up-regulated in the gastric cancer tissues, which serves as an oncogene to inhibit the cell apoptosis by targeting tumor suppressor gene IFIT2 [21] . Wang et al. have suggested that the long non-coding RNA LINC00161 can sensitize the osteosarcoma cells to cisplatininduced apoptosis by regulating the miR-645-IFIT2 axis [22] . A recent study has also revealed that the inhibition of proteasome activity blocks the degradation of IFIT2 and promotes the aggregation of IFIT2 in the centrosome, which in turn induces cell apoptosis [8] . Therefore, the contribution of IFIT2 in promotion of cell apoptosis might encompass an anti-tumor mechanism for the translational regulation involving in cancerous transformation and inhibition of tumor colonization, and thus it could be used as a potential target for cancer therapeutics.
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